TradingView’s own chart and price feed. The page’s numbers are end-of-day closes.
Data provided by Databento (end of day). Next close = the first close after a story against the close before it; official daily closes only, not a call, not advice.
The numbers
fiscal 2025, as filed with the SEC · 66-metric EOD snapshot via Databento
Market cap$2.2B
Enterprise value$2.1B
Revenue$1.5M −78.0%
True FCF (ex-SBC)$-249.9M −33.8%
Rule of 40-13907.1%
ROIC-57.7%
True FCF Yield-11.5%
EPS, diluted$-3.90 −59.2%
Modern Valuation (EOD)
Market Cap$2.2B
Enterprise Value$2.1B
EV / True FCF—
EV / FCF—
EV / Gross Profit—
EV / EBIT—
EV / Sales1381.63
P / E (GAAP)—
P / FCF—
P / Oper. CF—
P / Book4.10
Owner & Cash Yields
True FCF Yield-11.5%
FCF Yield-9.9%
Owner Earn. Yield-13.6%
Earnings Yield-12.0%
Shareholder Yield—
Buyback Yield—
Dividend Yield—
Dividend / sh—
Payout Ratio—
FCF / sh$-2.72
EPS (diluted)$-3.90
Compounder & Returns
Rule of 40-13907.1%
ROIC-57.7%
Cash ROIC (CROIC)-42.9%
GP / Assets—
ROE-49.1%
ROA-44.4%
Gross Margin—
Oper. Margin-18599.8%
Net Margin-16748.0%
FCF Margin-13829.1%
True FCF Margin-16173.2%
Quality & Dilution
Cash Conversion—
Accrual Ratio−8.2%
SBC % of FCF—
SBC % of Rev2344.1%
Reinvest. Rate—
Sales Growth Y/Y−78.0%
Sales 3Y CAGR−13.1%
EPS Growth Y/Y−59.2%
FCF Growth Y/Y−33.8%
FCF 3Y CAGR—
Share Change Y/Y+3.1%
Balance Sheet & Scale
Revenue (FY)$1.5M
Gross Profit (FY)—
Oper. Income (FY)$-287.4M
GAAP Net Income$-258.8M
True FCF (ex-SBC)$-249.9M
Cash & Equiv$28.9M
Total Debt—
Net Cash (Debt)$28.9M
Net Cash % MCap+1.3%
Debt / FCF (yrs)—
Current Ratio10.4978.55M sh
Price & Technicals (EOD)
Perf Week−4.89%
Perf Month−5.35%
Perf Quarter−32.41%
Perf Half Y−10.77%
Perf YTD−19.02%
SMA 20 Dist−6.27%$29.25
SMA 50 Dist−11.31%$30.92
SMA 100 Dist−21.71%$35.03
Window High−38.89%$44.87
Window Low0.00%$27.42
RSI (14) · Vol38.746%v
Income Distribution & Cash Flow ConversionHow every dollar of CLDX revenue flows through cost of goods, operating expenses, taxes, GAAP net income, and dilution-adjusted free cash flow
Operating Cash Flow (OCF)$-210.9M(-13653.4% of rev)
Less: Capital Expenditures−$2.7M(175.7% of rev)
Standard Free Cash Flow (FCF)$-213.7M(-13829.1% margin)
Less: Stock-Based Comp (SBC)−$36.2M
True FCF (Owner Cash ex-SBC)$-249.9M(-16173.2% of rev)
Revenue by fiscal year
$4.7MFY21
$2.4MFY22
$6.9MFY23
$7.0MFY24
$1.5MFY25
Operating leverage — margins
GrossOperatingNet
Unlocked SEC EDGAR Accounting Statements (USD)All 3 statements · Common-size (% of Revenue / Assets) · YoY growth · Tap any core row to explain
Line Item (USD)
FY2021
FY2022
FY2023
FY2024
FY2025
YoY Δ
4Y CAGR
Trend
Income Statement
Revenue ▸
$4.7M
$2.4M
$6.9M
$7.0M
$1.5M
−78.0%
−24.1%
Cost of Revenue (COGS)
$100,000
$100,000
$300,000
$200,000
$200,000
+0.0%
+18.9%
Research & Development (R&D)
$53.3M
$82.3M
$118.0M
$163.6M
$245.1M
+49.8%
+46.4%
Operating Income (EBIT) ▸
$-71.2M
$-115.2M
$-154.5M
$-195.1M
$-287.4M
−47.3%
—
Interest Expense
—
—
—
—
$927,000
—
—
Income Tax Expense
$-227,000
—
$0
$0
$0
—
—
GAAP Net Income ▸
$-70.5M
$-112.3M
$-141.4M
$-157.9M
$-258.8M
−63.9%
—
Diluted EPS ▸
$-1.64
$-2.40
$-2.92
$-2.45
$-3.90
−59.2%
—
Diluted Shares
42,870
46,888
48.4M
64.4M
66.4M
+3.1%
+527.4%
Balance Sheet
Cash & Equivalents
$39.1M
$29.4M
$34.8M
$28.4M
$28.9M
+1.8%
−7.3%
Total Current Assets
$410.8M
$317.7M
$431.7M
$747.2M
$534.7M
−28.4%
+6.8%
Total Assets
$444.7M
$352.7M
$465.6M
$792.3M
$583.0M
−26.4%
+7.0%
Total Current Liabilities
$16.5M
$18.6M
$31.1M
$39.5M
$51.0M
+29.1%
+32.5%
Total Liabilities
$25.2M
$26.5M
$36.5M
$45.3M
$55.8M
+23.1%
+22.0%
Stockholders' Equity
$419.5M
$326.2M
$429.2M
$747.0M
$527.2M
−29.4%
+5.9%
Net Cash / (Net Debt)
$39.1M
$29.4M
$34.8M
$28.4M
$28.9M
+1.8%
−7.3%
Invested Capital
$380.3M
$296.8M
$394.4M
$718.6M
$498.3M
−30.7%
+7.0%
Cash Flow & Capital Allocation
Operating Cash Flow (OCF) ▸
$-60.9M
$-103.7M
$-107.3M
$-157.8M
$-210.9M
−33.7%
—
Depreciation & Amortization (D&A)
$3.1M
$2.9M
$3.0M
$3.2M
$3.4M
+6.4%
+2.5%
Stock-Based Compensation (SBC)
$9.0M
$15.6M
$23.9M
$34.2M
$36.2M
+5.8%
+41.8%
Capital Expenditures (CapEx)
$1.2M
$1.8M
$1.8M
$1.9M
$2.7M
+41.4%
+21.4%
Free Cash Flow (FCF) ▸
$-62.2M
$-105.6M
$-109.1M
$-159.7M
$-213.7M
−33.8%
—
True FCF (ex-SBC Owner Cash)
$-71.1M
$-121.2M
$-133.0M
$-193.9M
$-249.9M
−28.8%
—
Fundamentals, income distribution and multi-year statements from SEC EDGAR filings (public domain). Valuation multiples, performance and technicals computed from Databento 1D EOD closes. For information only, not investment advice.
On the Wire
what CLDX did at the next close after each story
No Wire story has named CLDX yet.
The Wire at 7 AM ET, free. Top stories with a bull and a bear case on each, every morning. No account needed.
What happened · big days
27 big days in a year, and what we hold on each
A big day is a close more than 4.88% from the one before, three times CLDX’s median day (1.63%). On 2 of the 27, its peer group moved the same way at least half as far. We show what we hold. We never name a cause.
every other trading daya big day, numbered in the list below±4.88%Hover a bar for its day. Click a big day to open it.
Shaded: since our stories began, Jun 10. Tap a bar for its day.
#DayCLDXWhat we hold that dayGroup (median of 4) · each
1 Dec 4, 2025+6.44%
Before our storiesgroup +1.7%, did not move with it
1Dec 4, 2025+6.44%
Before our stories
+1.7% did not move with itNTLA +7.5 · LNTH +3.5 · NEOG −0.2 · IDXX −1.2
2 Dec 9, 2025−5.74%
Before our storiesgroup −1.3%, did not move with it
2Dec 9, 2025−5.74%
Before our stories
−1.3% did not move with itLNTH −2.2 · NTLA −1.5 · IDXX −1.1 · NEOG +6.0
3 Dec 22, 2025+6.52%
Before our storiesgroup +1.7%, did not move with it
3Dec 22, 2025+6.52%
Before our stories
+1.7% did not move with itNTLA +5.1 · LNTH +3.2 · IDXX +0.3 · NEOG −1.0
4 Jan 5, 2026−5.22%
Before our storiesgroup +2.2%, did not move with it
4Jan 5, 2026−5.22%
Before our stories
+2.2% did not move with itNTLA +1.7 · IDXX +1.8 · LNTH +2.5 · NEOG +3.7
5 Jan 7, 2026+5.63%
Before our storiesgroup +0.3%, did not move with it
5Jan 7, 2026+5.63%
Before our stories
+0.3% did not move with itNTLA +4.1 · IDXX +1.1 · NEOG −0.4 · LNTH −0.4
6 Jan 12, 2026−6.25%
Before our storiesgroup +0.7%, did not move with it
6Jan 12, 2026−6.25%
Before our stories
+0.7% did not move with itNEOG −2.6 · LNTH −0.1 · IDXX +1.6 · NTLA +10.1
7 Jan 28, 2026−5.57%
Before our storiesgroup −1.7%, did not move with it
7Jan 28, 2026−5.57%
Before our stories
−1.7% did not move with itNTLA −6.8 · LNTH −2.3 · IDXX −1.0 · NEOG +1.0
8 Feb 5, 2026−6.96%
Before our storiesgroup −0.8%, did not move with it
8Feb 5, 2026−6.96%
Before our stories
−0.8% did not move with itNTLA −10.3 · LNTH −1.6 · IDXX +0.1 · NEOG +0.5
9 Feb 6, 2026+5.23%
Before our storiesgroup +1.1%, did not move with it
9Feb 6, 2026+5.23%
Before our stories
+1.1% did not move with itNTLA +10.7 · NEOG +2.0 · IDXX +0.2 · LNTH +0.1
10 Feb 23, 2026+5.65%
Before our storiesgroup −1.3%, did not move with it
10Feb 23, 2026+5.65%
Before our stories
−1.3% did not move with itNTLA +4.1 · LNTH −0.6 · IDXX −2.0 · NEOG −2.1
11 Feb 25, 2026+24.07%
Before our storiesgroup +1.0%, did not move with it
11Feb 25, 2026+24.07%
Before our stories
+1.0% did not move with itLNTH +2.9 · IDXX +1.3 · NEOG +0.7 · NTLA −1.2
12 Mar 19, 2026+5.22%
Before our storiesgroup −1.1%, did not move with it
12Mar 19, 2026+5.22%
Before our stories
−1.1% did not move with itIDXX +0.5 · NTLA −0.5 · NEOG −1.8 · LNTH −2.8
13 Mar 31, 2026+7.60%
Before our storiesgroup +4.0%, moved with CLDX
13Mar 31, 2026+7.60%
Before our stories
+4.0% moved with CLDXNTLA +10.0 · NEOG +4.3 · LNTH +3.8 · IDXX +0.9
14 May 11, 2026−4.97%
Before our storiesgroup −1.7%, did not move with it
14May 11, 2026−4.97%
Before our stories
−1.7% did not move with itIDXX −5.0 · NEOG −4.4 · LNTH +1.1 · NTLA +2.3
15 Jun 29, 2026+6.18%
Nothing on CLDXgroup −1.6%, did not move with it
15Jun 29, 2026+6.18%
Nothing on CLDXNo CLDX story, brief or results filing in our record that day
−1.6% did not move with itLNTH −0.2 · NTLA −0.4 · IDXX −2.8 · NEOG −5.0
16 Jul 7, 2026+5.22%
Nothing on CLDXgroup −0.3%, did not move with it
16Jul 7, 2026+5.22%
Nothing on CLDXNo CLDX story, brief or results filing in our record that day
−0.3% did not move with itIDXX +0.9 · LNTH +0.6 · NEOG −1.3 · NTLA −2.3
17 Jul 16, 2026−7.60%
Nothing on CLDXgroup +2.1%, did not move with it
17Jul 16, 2026−7.60%
Nothing on CLDXNo CLDX story, brief or results filing in our record that day
+2.1% did not move with itNTLA −9.1 · LNTH +0.8 · IDXX +3.4 · NEOG +3.5
18 Jul 29, 2026+5.42%
Nothing on CLDXgroup −0.4%, did not move with it
18Jul 29, 2026+5.42%
Nothing on CLDXNo CLDX story, brief or results filing in our record that day
−0.4% did not move with itNEOG +2.3 · IDXX +0.0 · NTLA −0.8 · LNTH −2.6
19 Aug 5, 2026+5.15%
Nothing on CLDXgroup −1.8%, did not move with it
19Aug 5, 2026+5.15%
Nothing on CLDXNo CLDX story, brief or results filing in our record that day
−1.8% did not move with itLNTH +0.4 · IDXX −0.6 · NTLA −3.1 · NEOG −3.5
20 Aug 13, 2026−5.04%
Nothing on CLDXgroup −0.2%, did not move with it
20Aug 13, 2026−5.04%
Nothing on CLDXNo CLDX story, brief or results filing in our record that day
−0.2% did not move with itNTLA −2.1 · IDXX −0.6 · LNTH +0.2 · NEOG +3.8
21 Sep 14, 2026+6.18%
Nothing on CLDXgroup +1.0%, did not move with it
21Sep 14, 2026+6.18%
Nothing on CLDXNo CLDX story, brief or results filing in our record that day
+1.0% did not move with itNEOG +1.4 · NTLA +1.1 · IDXX +1.0 · LNTH +0.1
22 Sep 22, 2026−11.56%
Nothing on CLDXgroup +2.0%, did not move with it
22Sep 22, 2026−11.56%
Nothing on CLDXNo CLDX story, brief or results filing in our record that day
+2.0% did not move with itLNTH −0.3 · IDXX +1.2 · NEOG +2.7 · NTLA +3.9
23 Sep 23, 2026−7.13%
Nothing on CLDXgroup −1.4%, did not move with it
23Sep 23, 2026−7.13%
Nothing on CLDXNo CLDX story, brief or results filing in our record that day
−1.4% did not move with itNEOG −2.9 · NTLA −2.8 · LNTH −0.0 · IDXX +0.1
24 Oct 19, 2026+7.77%
Nothing on CLDXgroup −0.3%, did not move with it
24Oct 19, 2026+7.77%
Nothing on CLDXNo CLDX story, brief or results filing in our record that day
−0.3% did not move with itNTLA +1.4 · LNTH +0.2 · IDXX −0.8 · NEOG −1.5
25 Nov 5, 2026−5.55%
Nothing on CLDXgroup −5.1%, moved with CLDX
25Nov 5, 2026−5.55%
Nothing on CLDXNo CLDX story, brief or results filing in our record that day
−5.1% moved with CLDXNTLA −9.8 · NEOG −6.3 · IDXX −4.0 · LNTH −0.4
26 Nov 6, 2026+5.66%
Resultsgroup +0.7%, did not move with it
26Nov 6, 2026+5.66%
ResultsFirst close after the Nov 5 results filing
+0.7% did not move with itNTLA +2.3 · IDXX +0.8 · NEOG +0.7 · LNTH −0.1
27 Nov 12, 2026−5.37%
Nothing on CLDXgroup −2.1%, did not move with it
27Nov 12, 2026−5.37%
Nothing on CLDXNo CLDX story, brief or results filing in our record that day
−2.1% did not move with itNTLA −7.5 · NEOG −3.5 · IDXX −0.7 · LNTH −0.3
A story on the same day is not a cause, and a group move is not proof either. Group: the median of IDXX, LNTH, NEOG and NTLA that day, the largest companies in CLDX’s SEC industry; “moved with CLDX” means the same direction and at least half the size.
What’s next · results
Before the next report: what the first day after the last four did
Six trading days after each results filing (SEC 8-K, Item 2.02). CLDX reports after the close, so day 1 is the next close. 3 of 4 times, day 6 ended on the same side as day 1.
Reported Feb 25, 2026
day 1−0.58%day 6−4.74%
Reported May 7, 2026
day 1+1.95%day 6−5.94%
Reported Aug 6, 2026
day 1+0.36%day 6+0.94%
Reported Nov 5, 2026
day 1+5.66%day 6+1.98%
Next report: expected early-to-late FebruaryEstimated from the dates of its last four results filings. Not announced. Since the Nov 5 report: −1.10%. Four reports is a small sample.
Each line is CLDX’s close against its close before the filing, on licensed end-of-day closes. What happened after each report, not a forecast; a move on the day is not a cause.
Same industry
CLDX against four same-industry peers, a year at 100
CLDX is up 7.9% in a year. Neogen is up 89.7%, Lantheus Holdings 82.9% and Intellia Therapeutics 16.0%. Of these four, only Idexx Laboratories (−5.0%) did less. Weekly closes, Nov 21, 2025 = 100, on a log scale, so the same percentage move is the same height on every line.
End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in CLDX’s SEC industry (In Vitro & In Vivo Diagnostic Substances) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.